Sign In
Free Newsletter
Wall Street ends higher, S&P 500, Nasdaq notch biggest monthly gains in years
Wall Street stocks rose with the S&P 500 and Nasdaq logging their biggest monthly gains in years amid strong earnings and easing oil prices.
Drugmakers face 100% tariff unless they cut prices or produce drugs in US
The Trump administration will impose 100% tariffs on imported branded pharmaceuticals unless drugmakers cut prices or produce drugs in the US.
Wall Street ends higher on speculation about end to Iran war
Wall Street closed higher as President Donald Trump suggested a quick U.S. exit from Iran, boosting tech stocks and easing energy price fears.
Virginia Business announces Top Projects/Real Estate Deals awards
In July, Virginia Business will introduce its inaugural Virginia Top Projects & Real Estate Deals recognition program, honoring the innovative buildings, facilities and transactions reshaping Virginia’s landscape. (Applications are due April 17 and can be submitted at virginiabusiness.com/event/top-projects/.) Top Projects will spotlight the best building and construction projects delive[...]
Preparation, pandemic helped Virginia land Big Pharma deals
Virginia attracted $12 billion in pharmaceutical manufacturing investments in 2025, leveraging site readiness, workforce training, and strong infrastructure.
Giant economic development deals took spotlight in 2025
Virginia's 2025 saw major data center and pharmaceutical investments driving growth despite federal workforce declines and budget challenges.
Eli Lilly’s Goochland $5B plant to benefit region and beyond
Eli Lilly is investing $5 billion in a Goochland pharmaceutical plant to create 650 jobs and produce advanced therapies, strengthening Virginia’s pharma sector.
Lilly bets on next-generation cell therapy with $2.4B deal for Orna
Eli Lilly agreed to buy Orna Therapeutics for up to $2.4 billion, gaining in vivo CAR-T and circular RNA technology platform.
Aktis Oncology secures Lilly as anchor investor for upsized US IPO
Jan 7 (Reuters) – Cancer drug developer Aktis Oncology said on Wednesday it was targeting a valuation of up to $945.4 million in its upsized initial public offering, signaling strong investor demand for 2026’s first U.S. listing. The Boston, Massachusetts-based company has also drawn in Eli Lilly to anchor the IPO, with the pharma giant […]
Dow, S&P 500 hit records despite AI stock slump
NEW YORK (AP) — Wall Street set records on Thursday, even as a sell-off for Oracle and worries about a potential bubble in artificial-intelligence technology weighed on the market. The S&P 500 inched up 0.2% and eked past its prior all-time closing high, which was set in October. The Dow Jones Industrial leaped 646 points, or 1.3%, to top its […]
2025: The year of living disruptively
Looking back on 2025, the best symbol of the past year’s upheaval might be the White House, if not its most famous occupant. Since moving back into 1600 Pennsylvania Ave. in January, our real estate mogul president has launched into a series of home renovations worthy of its own HGTV series. The most prominent changes […]
FOR THE RECORD December 2025
Central Virginia Pharmaceutical giants AstraZeneca, Eli Lilly & Co. and Merck & Co. have committed a cumulative $120 million to develop a workforce training center for advanced pharmaceutical manufacturing in Central Virginia. The companies, each of which plans to build major manufacturing facilities in Virginia; the state government, including Virginia Innovation Partnership Corp.; and [...]
